<PAGE>
- --------------------------------------------------------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
--------------------------
FORM 10-Q/A
--------------------------
[CHECK MARK HERE] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the Quarter ended June 30, 1996
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from ______ to _______.
Commission File Number: 0-11371
--------------------------
BIOSONICS, INC.
(Exact name of registrant as specified in its charter)
Pennsylvania 23-2161932
(State or other jurisdiction of (IRS Employer Identification No.)
incorporation or organization)
260 New York Drive
Fort Washington, Pennsylvania 19034
(Address of principal executive offices)
(215) 646-7100
(Registrant's telephone number including area code)
----------------------------------------------------------
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports) and (2) has been subject to such filing
requirements for the past 90 days.
Yes [CHECK MARK HERE] No
----------------- ----
As of August 19, 1996, there were outstanding 243,333,936 shares of the
Registrant's Common Stock, $.0001 par value.
- --------------------------------------------------------------------------------
Page 1 of 13 pages
Exhibit Index is on Page 12
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunder duly authorized.
BIOSONICS, INC.
Date: August 19, 1996
By:
--------------------------
Jack Paller, President, Chairman
and Executive Officer, Principal
Financial Officer and Principal
Accounting Officer
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<CIK> 0000352715
<NAME> BIOSONICS, INC.
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-1996
<PERIOD-START> APR-01-1996
<PERIOD-END> JUN-30-1996
<CASH> 260
<SECURITIES> 0
<RECEIVABLES> 22,211
<ALLOWANCES> 6,000
<INVENTORY> 65,889
<CURRENT-ASSETS> 94,558
<PP&E> 233,006
<DEPRECIATION> 210,665
<TOTAL-ASSETS> 125,330
<CURRENT-LIABILITIES> 2,680,975
<BONDS> 435,444
10,900
0
<COMMON> 24,333
<OTHER-SE> (2,555,645)
<TOTAL-LIABILITY-AND-EQUITY> 125,330
<SALES> 29,125
<TOTAL-REVENUES> 29,200
<CGS> 16,166
<TOTAL-COSTS> 220,238
<OTHER-EXPENSES> 37,000
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 11,402
<INCOME-PRETAX> (244,204)
<INCOME-TAX> 0
<INCOME-CONTINUING> (244,204)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (244,204)
<EPS-PRIMARY> .000
<EPS-DILUTED> .000
</TABLE>
